Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P V Halushka

Showing results (61-70 of 229) with videos related to

Pageof 23
Sort By:
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1979
The effects of alpha adrenergic agents on human platelet aggregationC Y Hsu, D R Knapp, P V Halushka
Diabetes Care|January 1, 1981
Pathogenesis of atherosclerosis in diabetes mellitusJ A Colwell, M Lopes-Virella, P V Halushka
Advances in Shock Research|January 1, 1981
Implications for thromboxane A2 in the pathogenesis of endotoxic shockW C Wise, J A Cook, P V Halushka
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1979
Vasopressin stimulates thromboxane synthesis in the toad urinary bladder: effects of imidazoleR M Burch, D R Knapp, P V Halushka
Methods in Enzymology|January 1, 1990
Radioligand binding assays for thromboxane A2/prostaglandin H2 receptorsP V Halushka, T A Morinelli, D E Mais
Biochimica Et Biophysica Acta|March 10, 1994
Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptorsA K Okwu, D E Mais, P V Halushka
Advances in Shock Research|January 1, 1983
Arachidonic acid metabolism in endotoxin toleranceW C Wise, J A Cook, P V Halushka
Diabetes|May 1, 1983
Do platelets have anything to do with diabetic microvascular disease?J A Colwell, P D Winocour, P V Halushka
European Journal of Pharmacology|January 25, 1991
Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptorP R Mayeux, D E Mais, P V Halushka
Progress in Clinical and Biological Research|January 1, 1989
Thromboxane and prostacyclin receptorsP V Halushka, D E Mais, T A Morinelli
Pageof 23

Showing results (61-70 of 229) with videos related to

Sort By:
Pageof 23
The Journal of Pharmacology and Experimental Therapeutics|March 1, 1979
The effects of alpha adrenergic agents on human platelet aggregationC Y Hsu, D R Knapp, P V Halushka
Diabetes Care|January 1, 1981
Pathogenesis of atherosclerosis in diabetes mellitusJ A Colwell, M Lopes-Virella, P V Halushka
Advances in Shock Research|January 1, 1981
Implications for thromboxane A2 in the pathogenesis of endotoxic shockW C Wise, J A Cook, P V Halushka
The Journal of Pharmacology and Experimental Therapeutics|September 1, 1979
Vasopressin stimulates thromboxane synthesis in the toad urinary bladder: effects of imidazoleR M Burch, D R Knapp, P V Halushka
Methods in Enzymology|January 1, 1990
Radioligand binding assays for thromboxane A2/prostaglandin H2 receptorsP V Halushka, T A Morinelli, D E Mais
Biochimica Et Biophysica Acta|March 10, 1994
Agonist-induced phosphorylation of human platelet TXA2/PGH2 receptorsA K Okwu, D E Mais, P V Halushka
Advances in Shock Research|January 1, 1983
Arachidonic acid metabolism in endotoxin toleranceW C Wise, J A Cook, P V Halushka
Diabetes|May 1, 1983
Do platelets have anything to do with diabetic microvascular disease?J A Colwell, P D Winocour, P V Halushka
European Journal of Pharmacology|January 25, 1991
Interactions of dihydropyridine Ca2+ channel agonists with the human platelet thromboxane A2/prostaglandin H2 receptorP R Mayeux, D E Mais, P V Halushka
Progress in Clinical and Biological Research|January 1, 1989
Thromboxane and prostacyclin receptorsP V Halushka, D E Mais, T A Morinelli
Pageof 23